Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
CWRH/UH researcher receives grant to study role of KLF2 factor in vascular-related disorders

CWRH/UH researcher receives grant to study role of KLF2 factor in vascular-related disorders

Transcription factors are proteins that determine whether specific genes are transcribed or not by binding to DNA. In other words, they help turn genes “on” or “off.”

One such transcription factor, Kruppel-like factor (KLF) 2, plays a central role in many processes critical to cardiovascular homeostasis. Researchers also understand that levels of KLF2 increase with health and decline with disease. “We are very keen to identify the cellular pathways that regulate the increase or decrease in KLF2 levels in order to develop novel strategies to sustain levels and ameliorate cardiovascular disorders,” said Mukesh K. Jain, MD, professor of medicine at Case Western Reserve University School of Medicine and the Ellery Sedgwick Jr. Chair & Distinguished Scientist, University Hospitals Cleveland Medical Center. He is part of a trans-Atlantic network of international leaders in cardiovascular medicine who aim to find out.

Jain and his colleagues have been awarded a five-year, $6M grant from the Paris-based Fondation Leducq to conduct a thorough analysis of the pivotal role of KLF2 in vascular-related functions and disorders. The team’s grant was one of five awarded globally and is, in the French foundation’s words, “an indication of [our] enthusiasm for your proposal, and faith that the collaborative work of the network will significantly improve our knowledge and treatment of cardiovascular disease.”

Joining Jain as part of the research team are eminent researchers from Yale University, the University of Oxford, the University of Pennsylvania, and the Max Planck Institute for Molecular Biomedicine in Germany.

KLF2 and members of this family of transcription factors regulate hundreds of genes that control blood vessel function, often simultaneously, turning on and standardizing a coordinated genetic program governing vascular health. This includes the development of new blood vessels in embryos and adults and embryonic heart valve formation. KLF2 is also a major anti-inflammatory and anti-clotting agent, thereby promoting vascular health. But lower levels of KLF2 can cause inflammation and narrowing of the arteries, resulting in blockages in blood vessels, conditions that affect tens of millions of people worldwide. Additionally, the effects of cardiac medicines known as statins are mediated in part through KLFs.

How is KLF2 involved in such a broad range of life-sustaining activities and potentially lethal breakdowns?

To help answer this question, Jain and his colleagues have three aims. First, determine how KLF2 actually functions within a cell. This entails illuminating the cellular machinery it uses in controlling vascular processes. Second, determine what specific genes with blood vessels it targets to turn on and off. Third, test the findings of aims one and two in both human tissues and relevant mouse genetic models. The team expects that these studies will reveal the full KLF2 regulatory set of connections and identify new treatment targets for cardiovascular disease. The team will use insights from its studies on KLF2 to conduct analysis of KLF4, a related molecule with similar functions.

“KLFs are now known to serve as master regulators of the endothelium, the tissue that forms a single layer of cells lining the blood vessels, heart, and lymphatic vessels,” said Jain. “Studying the mechanisms of KLF2 expression and its involvement in vascular physiology, and gaining an ability to control that function, have the potential to treat a broad array of cardiovascular diseases ranging from stroke and heart attack to brain-based cerebrovascular malformations.”

Among its techniques, the research team will use CRISPR-Cas9-based approaches to delete certain genes in the KLF2 sequencing process and determine what affect this has on vascular development and function. This will help specify which genes are involved in various processes and diseases, boosting overall understanding and identifying targets for treatment, either through medication or gene-editing. The researchers will also utilize already FDA-approved medications on human cells and mice, seeking to determine which ones might be used to target the findings of the investigative team.

This work builds on seminal findings Jain published in 2004 that led to the discovery of KLFs in vascular biology. While KLFs were known to regulate critical functions based on studies in the 1970’s and 1980’s in flies, the link to cardinal functions of blood vessels was amongst the first in mammalian systems and represented a major advance in cardiovascular biology. KLFs have also been implicated in numerous biological processes that affect the development of cancer, metabolic disorders, immune dysfunction, and aging.​

Source:

http://casemed.case.edu/cwrumed360/news-releases/release.cfm?news_id=1548&news_category=8

Tagged with:

About author

Related Articles